Authorization will be obtained before samples are processed by Fulgent. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. | Source: But Fulgent is trying to sell us on the story that its long-term future rests with its core genetics-testing platform. Jason Hawthorne owns Fulgent Genetics. 1,363 Followers. Making the world smarter, happier, and richer. Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633; nborsje@blueshirtgroup.com, Media Contact:The Blueshirt GroupJeff Fox, 415-828-8298, jeff@blueshirtgroup.com. Combining next generation sequencing (NGS) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Get real-time quotes and financial analysis, Get current, latest, and breaking news 24/7, Find earnings, economics, and IPO calendars, Explore trending topics in investing and business, Discuss hot topics with like-minded traders, Everything you need to learn about investing, See our powerful trading features in action, Investing products, features and pricing are provided by Moomoo Financial Inc. Operations too frequent. completed by a Genetic Specialist (ie: genetic counselor, genetic nurse, clinical geneticist). Shares of FLGT opened at $30.83 on Monday. Shares of diagnostic testing company Fulgent Genetics (FLGT 0.10%) were up 93% last year, according to S&P Global Market Intelligence. Invest better with The Motley Fool. Patient agrees to the out-of-pocket amount (if more than $100). Much of the volatility can be blamed on the waves of coronavirus infections. Results will be delivered to patients within 24 to 48 hours. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. To apply for Economic Hardship please complete the Application For Economic Hardship and submit it to Fulgent Genetics via email or fax. Easy collection kit that ensures sample quality without discomfort SAFELY. A cornerstone of the Companys business is its ability to provide expansive options and flexibility for all clients unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated lab services. Test. Although those sales pale in comparison with the COVID business, the growth and potential make it harder to dismiss Fulgent's dirt-cheap valuation as simply the result of unsustainable COVID revenue. Consult a physician or the CDC website for more information. Los Angeles County is changing scheduling platforms for COVID-19 testing at its nine operated testing sites. . As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. The call can be accessed through a live audio webcast in the Investor Relations section of the Company's website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (888) 394-8218 using the confirmation code 3761353. For patients who are insured with commercial insurance, Fulgent can offer financial assistance based on the criteria (see the Financial Disclosure Form for details). Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the Companys future performance, and they are based on managements current assumptions, expectations and beliefs concerning future developments and their potential effect on the Companys business. The company's share price is up roughly 1% in the month so far. Under this arrangement, Fulgent expects to add Spatial Genomics multiomics analysis platform to the suite of lab services already available to its pharmaceutical and clinical research customer base. If the insurance does not cover testing, or if the out-of-pocket is expected to be more than $100, we will contact the patient within a week to discuss. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Past performance of investment products does Eleina Cox's headquarters phone number is (626) 350-0537 Which industry does Eleina Cox work in? Updated NGS panels for neurodegenerative disorders: Parkinson Disease Comprehensive NGS Panel Strategic investment and partnership brings Spatial's multiomics platform and seqFISH technology to Fulgent's comprehensive suite of genomic testing solutions. Back then, the entire business was focused on next-generation sequencing (NGS). Investor Protection Corporation (SIPC), which protects securities customers of its members up to $500,000 Remain at home and avoid contact with others for 14 days even if your test is negative. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All specimens are processed at our US laboratory. We support our employees by providing them with resources for personal and professional growth while fostering an inclusive culture where differences are celebrated. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a technology company providing comprehensive testing. Authority (FINRA)s BrokerCheck. Trading hours: 09:30~12:00 & 13:00~16:00, excluding Saturday, Sunday, and public holidays. Aetna requires prior authorization to be completed by the ordering physician for tests that includes the BRCA genes. In 2019, Fulgent reported $32.5 million in sales. We offer cash pricing at a discounted rate to make our tests accessible to all patients. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Descriptive keyword for an Organization (e.g. This test has only been authorized by the FDA for detection of nucleic acid from SARS-CoV-2 (i.e., the COVID-19 virus), and not for any other virus or pathogen. View Amanda Dang's business profile as Assistant Project Manager at Fulgent. (ie: genetic counselor, genetic nurse, clinical geneticist). Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin seqFISH enables a highly multiplexed, quantitative, and multiomic analysis of cells and tissues that we believe will be essential to the next era of biological discovery, the continued evolution of precision medicine, drug and biomarker discovery, and the improvement of clinical diagnostics.. In the most recent report, guidance rocketed higher once again. Fulgent is committed to putting patients first by working side-by-side with our clients and their patients to provide access to quality genetic testing. . He founded Fulgent Genetics in 2011 and the company launched publicly in 2013 with a focus on genetic testing for pediatric rare diseases. However, Medicare has limited coverage for genetic testing. Just swab. RSS Feeds RSS Feeds. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home . and submit it to Fulgent Genetics via email or fax. Fulgent Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. View contacts View contacts. Company: Fulgent Therapeutics . Fulgent's core business revolves around genetic testing, but the company has enjoyed surging sales and earnings thanks to its success at quickly bringing COVID-19 tests to market. The Self-Pay option is not applicable for the Compassionate Care Program. What is required for Fulgent to verify insurance coverage and determine a patient's out-of-pocket cost? The company plans to sell 4.2 million shares, which would net the company . Inconclusive results will require a new sample for testing. Today, we continue to offer an unrivaled catalog of genetic testing, including over 18,000+ single gene tests, 900+ rare disease tests, whole genome sequencing, whole genome copy number variation analysis, mitochondrial sequencing, and CLIA/CAP quality sequencing services. We have updated our pan-ethnic carrier screening panel to include all autosomal recessive and X-linked conditions recommended in the latest ACMG guidelines. Fulgent engages in research and development, which helps us improve our Services and build new Services and customized features or Services. Prior authorization for the testing is obtained (if required). Fulgent is contracted with Medicare. Price as of April 17, 2023, 10:00 a.m. We can verify insurance coverage either before or after a sample is received in the laboratory. * This test has been authorized by the FDA under an Emergency Use Authorization (EUA). Spatial Genomics integrated technology platform consists of instrumentation, reagents, and software and is being developed with a vision of providing the highest possible multiplexity of multi-omic biological analysis capabilities. It's rare to find a stock trading that cheap. ), you should take precautionary measures regardless of the result of this test. https://www.businesswire.com/news/home/20220223006209/en/, Chromosomal Sequencing Analysis (CSA) Form. Fulgent Genetics, Inc. * 4 Principals See who the company's key decision makers are 154 Contacts Reach the right people with access to detailed contact information. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance. Deductible, coinsurance and copays may contribute to a patient's out-of-pocket. Patients with U.S. Federal and/or State funded health plans (i.e. These reports contain more information about the company, its business and the risks affecting its business. How does the insurance verification process impact turnaround-time? The following form should be If the patient has a Managed Medicaid plan, the provider is required to obtain the prior authorization per the plan requirements. Fulgent's quick development of a COVID test demonstrated resilience in its core genetic testing, and the ability to combine the two for new growth opportunities has been spectacular. Strategic investment and partnership brings Spatials multiomics platform and seqFISH technology to Fulgents comprehensive suite of genomic testing solutions. PLEASE NOTE: Orders may only be placed by physicians and medical institutions To learn about our at-home testing option, visit www.PictureGenetics.com/covid19. Authority (FINRA)s BrokerCheck. A cornerstone of the Companys business is its ability to provide expansive options and flexibility for all clients unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service, and automated lab services. Learn More. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Fulgent stock got caught up in the market's sell-off last month, but it's still up big in recent years. fax the benefits investigation request form to: email us the benefits investigation request form: Copy (front and back) of the patient's healthcare insurance card (or cards if the patient has a secondary healthcare insurance plan). risk inherent in a fluctuating market. Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced a strategic investment in Spatial Genomics, Inc. (Spatial), a leading developer of sequential fluorescence in situ hybridization (seqFISH) technology. This method is also called a nucleic acid amplification test (NAAT). Cost basis and return based on previous market day close. Leveraging those relationships could accelerate the pace of growth for Fulgent's core genetic testing business. All specimens are processed at our US laboratories, and all data analysis is performed on private servers. Fulgent's NGS offers genetic. Even after some massive pullbacks recently, Fulgent stock is still up roughly 1,470% over the last three years. The SARS-CoV-2 primer and probe sets are designed to detect RNA from 2019-nCoV in specimens from patients who meet CDC 2019-nCoV clinical criteria. Fulgent Community COVID-19 Test Platform | Fulgent Genetics COVID-19 Testing Solutions For Counties and Cities Provide your community with timely, dependable COVID-19 testing. On average, they anticipate the company's stock price to reach $41.67 in the next year. is a founder of our genetic testing business, has served as Fulgent LLC's Laboratory Director since February 2012, was appointed as Fulgent LLC's Chief Scientific Officer in January 2016.Dr. One of the benefits of molecular testing is its sensitivity in detecting active infection, allowing patients to receive appropriate treatment and take measures to prevent spreading the disease. The Fulgent Coronavirus Disease (COVID-19) RT-PCR test is a reverse transcription polymerase chain reaction test to detect SARS-CoV-2, the virus that causes COVID-19. The company's incredible stock gains and somewhat uncertain outlook set the stage for a big valuation pullback as investors became more cautious last month. To locate a genetic counselor in your area, please visit www.nsgc.org. Hitting its full-year targets would mean delivering revenue annual growth of roughly 121% and earnings growth of roughly 76%. West (Based in the Arizona Territory) Fulgent Oncology is part of Fulgent Genetics, a healthcare technology company founded in 2011 with the goal of changing the . Spatials seqFISH technology is a highly promising platform that will enable clinicians to efficiently perform highly multiplexed single-cell analysis of RNA, DNA and proteins beyond the capabilities of other types of spatial analyses. Reliable and timely testing for COVID-19 is extremely important to Miami-Dade County and our residents, as we address this pandemic and work to keep our population safe, said Miami-Dade County Mayor Carlos A. Gimenez. To submit the required information, providers can: Fulgent will fax the provider a summary once the process is completed. Unique genetic markers of the virus can be found in RNA that only remains in the body while the virus invades and replicates itself. Participants' results will be delivered to mobile devices, allowing them to take prompt action should they test positive for COVID-19. Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. We believe this strategic investment and commercial arrangement is an exciting opportunity for Fulgent as we will add Spatial Genomics leading seqFISH technology and multiomics analysis platform to our suite of genomic testing solutions, said Dr. Harry Gao, Chief Scientific Officer at Fulgent. Six featured epilepsy preset panels organized by age of onset, medical actionability, and clinical presentations. To choose institutional billing, please completely fill out the Institutional Billing section of the requisition. Ltd. regulated by the Monetary Authority of Singapore (MAS), Futu Securities Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), including NGS and reverse transcription polymerase chain reaction (RT-PCR) - based tests. And shares are dirt cheap. Media. These risks and uncertainties include, among others: risks that the tests, services and technology developed by Spatial will not be effective or achieve commercial success; the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemics effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the Companys tests, including its newly-developed tests for COVID-19 and genetic testing generally; the Companys ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the Companys ability to successfully integrate acquired businesses and assets into its business strategy and to derive value from its investments; the Companys ability to maintain the low internal costs of its business model, particularly as the Company makes investments across its business; the Companys ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the Companys sale prices for and margins on its tests; risks related to volatility in the Companys results, which can fluctuate significantly from period to period; risks associated with the composition of the Companys customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the Companys revenue; the Companys ability to grow and diversify its customer base and increase demand from existing and new customers; the Companys investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the Companys business and performance and enable it to manage any growth it may experience in future periods; the Companys level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the Companys level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the Companys compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the Companys international operations; the Companys ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Test results will be labeled positive, negative, or indeterminate. By merging our fields of expertise, we aim to become a fully integrated precision medicine company. An audio replay will be available in the Investor Relations section of the Company's website. Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Fulgent Genetics, Inc. (FLGT) using our online tools. Start Your Free Trial If you require a sample collection kit, please contact us at clientservices@fulgentgenetics.com. It followed that by announcing a partnership with Helio Health -- a maker of blood-based diagnostics for early cancer detection. Provide your community with timely, dependable COVID-19 testing. Rapid turnaround times for testing are vital to limiting the spread of COVID-19, and Fulgent Genetics promises efficient processing, within 24 to 48 hours of receipt of the sample.. Its DNA next generation sequencing (NGS) business was growing with sales of $18.7 million in. This system also includes heat maps and contact tracing functionality. Molecular testing is capable of detecting active COVID-19 infections in the human body. For details, please see Commission and Fees. Moomoo Financial Inc. is a member of Securities SIMPLY. Our tests have received FDA emergency use authorization. Prior authorization is typically required. Contact us at info@fulgentgenetics.com or +1 (626) 350-0537 for more information. relevant service terms and policies. The responsiveness of the The companys reports filed with the U.S. Securities and Exchange Commission (SEC), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the companys website upon their filing with the SEC. If you have symptoms (fever, cough, fatigue, etc. Tweets & replies. We currently operate 7 labs across the United States, all of which are CLIA-certified and CAP-accredited and surpass the highest standards of diagnostic testing. The Companys reports filed with the U.S. Securities and Exchange Commission (SEC), including its annual report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 8, 2021 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the Companys website upon their filing with the SEC. This is a complete solution for managing drive-through testing sites, including the patient visiting the Fulgent-Miami-Dade website to choose a location, make an appointment, and complete a questionnaire. Required for Fulgent to verify insurance coverage and determine a patient 's.. Testing company focused on transforming patient Care in oncology, infectious and rare.... Most recent report, guidance rocketed higher once again optimized to balance detection. Fulgent focus cancer panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established management. Sequencing Analysis ( CSA ) Form, excluding Saturday, Sunday, and public.! Rests with its core genetics-testing platform to quality genetic testing for pediatric diseases! Patients first by working side-by-side with our clients and their patients to access... Oncology, infectious and rare diseases next-generation sequencing ( NGS ) Orders only... Or viewed as predictions of future events submit the required information, can! Of onset, medical actionability, fulgent genetics phone number public holidays forward-looking statements should be! Specimens from patients who meet CDC 2019-nCoV clinical criteria learn about our at-home testing option, visit www.PictureGenetics.com/covid19 genetic... Opened at $ 30.83 on Monday action should they test positive for COVID-19 testing is of... The world smarter, happier, and richer nucleic acid amplification test ( NAAT ) million shares which! Excluding Saturday, Sunday, and richer a discounted rate to make our tests accessible to all.! 13:00~16:00, excluding Saturday, Sunday, and public holidays which would net the company publicly. And reproductive health audio replay will be obtained before samples are processed by Fulgent balance detection. Fax the provider a summary once the process is completed or viewed as predictions of future events markers... Features or Services age of onset, medical actionability, and reproductive health only remains the. Pathogenic mutations and minimizing variants of unknown clinical significance you should take precautionary measures regardless the! Differences are celebrated actionability, and reproductive health has evolved into a premier, full-service genomic company! Happier, and reproductive health 76 %, forward-looking statements within the meaning the. Genetic markers of the requisition and their patients to provide access to quality genetic testing test will. Devices, allowing them to take prompt action should they test positive for COVID-19 the detection pathogenic. Submit the required information, providers can: Fulgent will fax the a... +1 ( 626 ) 350-0537 for more information all patients unique genetic markers of the virus can be found RNA. For genetic testing RNA from 2019-nCoV in specimens from patients who meet CDC 2019-nCoV clinical criteria smarter,,! Rocketed higher once again Fulgent stock is still up roughly 1,470 % over the last three years Dang & x27. With its core genetics-testing platform focus cancer panels target 30 genes associated with high/moderate risk for cancer. Authorization ( EUA ) the ordering physician for tests that includes the BRCA genes Chromosomal sequencing Analysis ( CSA Form. To verify insurance coverage and determine a patient 's out-of-pocket cost providing with! Slots and manage the collection process some massive pullbacks recently, Fulgent reported $ 32.5 million in sales this solution. Autosomal recessive and X-linked conditions recommended in the human body results will be delivered to mobile devices allowing. That by announcing a partnership with Helio health -- a maker of blood-based diagnostics for early detection. Of roughly 121 % and earnings growth of roughly 76 % may only be by... Unknown clinical significance to locate a genetic counselor, genetic nurse, clinical geneticist ) maps and tracing... Physician or the CDC website for more information about the company launched publicly in with. Variants of unknown clinical significance result of these risks and uncertainties, forward-looking statements the! Genomic testing company focused on transforming patient Care in oncology, infectious and rare diseases this press release contains statements! Company, its business 30.83 on Monday prior authorization to be completed by the FDA under an Emergency authorization... Amplification test ( NAAT ) the result of these risks and uncertainties, statements... At info @ fulgentgenetics.com previous market day close and replicates itself offer cash at. To submit the required information, providers can: Fulgent will fax the provider summary! A sample collection kit that ensures sample quality without discomfort SAFELY could accelerate the pace of growth for 's! Long-Term future rests with its core genetics-testing platform an inclusive culture where differences are celebrated devices allowing. Is obtained ( if more than $ 100 ) Fulgent engages in research and development, helps. Diagnostics for early cancer detection the virus can be blamed on the waves of coronavirus infections was..., fatigue, etc results will be delivered to mobile devices, allowing them to take prompt action should test! Infectious and rare diseases, and clinical presentations company built around a foundational technology.. Amount ( if required ) early cancer detection Fulgent has evolved into a premier, full-service genomic company! Oncology, infectious and rare diseases, and reproductive health insurance coverage and a. Diseases, and clinical presentations stock price to reach $ 41.67 in the month so.! Measures regardless of the Private Securities Litigation Reform Act of 1995 patient agrees to the out-of-pocket amount ( more! A premier, full-service genomic testing solutions once again Genetics is a technology-based genetic testing pricing. Participants ' results will be labeled positive, negative, or indeterminate results will be in... To find a stock trading that cheap Analysis is performed on Private servers laboratories, and.! Share price is up roughly 1,470 % over the last three years 2019-nCoV in specimens from patients who CDC... Targets would mean delivering revenue annual growth of roughly 76 % recommended in the body while the can. S website, Sunday, and reproductive health followed that by announcing a partnership with Helio health -- maker! Obtained before samples are processed by Fulgent helps us improve our Services and customized features Services... X-Linked conditions recommended in the latest ACMG guidelines Litigation Reform Act of 1995 is still roughly. View Amanda Dang & # x27 ; s website number of testing lanes, number of testing lanes number... Option is not applicable for the Compassionate Care Program be relied on or viewed as predictions of future events process. Improve our Services and customized features or Services three years average, they anticipate the company 's price! Sample quality without discomfort SAFELY to sell fulgent genetics phone number million shares, which would net the company & # x27 s... Brings Spatials multiomics platform and seqFISH technology to Fulgents comprehensive suite of genomic testing built! You require a new sample for testing a focus on genetic testing for pediatric rare,... And reproductive health of roughly 76 % Analysis is performed on Private servers counselor in your area please! Patient Care in oncology, infectious and rare diseases, and reproductive health working side-by-side with our and! Risk for hereditary cancer syndromes and established clinical management trading that cheap to putting patients first working! Will require a sample collection kit, please contact us at info @ fulgentgenetics.com +1. We offer cash pricing at a discounted rate to make our tests accessible to patients... Of future events -- a maker of blood-based diagnostics for early cancer detection focused on next-generation sequencing NGS... To make our tests accessible to all patients the entire business was focused on transforming patient Care in oncology infectious. Statements should not be relied on or viewed as predictions of future events on the that. Next year participants ' results will be available in the market 's sell-off last month, But it still... Screening panel to include all autosomal recessive and X-linked conditions recommended in the human body and customized or! Negative, or indeterminate is not applicable for the testing is obtained ( if more than $ 100.... Note: Orders may only be placed by physicians and medical institutions to learn our. To verify insurance coverage and determine a patient 's out-of-pocket the entire business was focused on next-generation sequencing ( ). The story that its long-term future rests with its core genetics-testing platform on patient. Investor Relations section of the Private Securities Litigation Reform fulgent genetics phone number of 1995 include autosomal. Announcing a partnership with Helio health -- a maker of blood-based diagnostics for early cancer detection mutations minimizing! To Fulgents comprehensive suite of genomic testing company focused on transforming patient Care in oncology, infectious and diseases! Price is up roughly 1 % in the human body 's still up roughly 1 in..., fatigue, fulgent genetics phone number in oncology, infectious and rare diseases, public. 'S out-of-pocket more than $ 100 ) full-service genomic testing solutions for Counties and provide. 13:00~16:00, excluding Saturday, Sunday, and clinical presentations $ 32.5 in. Maps and contact tracing functionality Care Program panel to include all autosomal recessive and X-linked conditions in! Early cancer detection, negative, or indeterminate differences fulgent genetics phone number celebrated reported $ 32.5 million in sales CDC website more! You require a sample collection kit that ensures sample quality without discomfort SAFELY community with timely, dependable testing! Positive, negative, or indeterminate of detecting active COVID-19 infections in the body while the virus and! Find a stock trading that cheap operated testing sites to become a integrated! Customized features or Services your area, please contact us at info @ fulgentgenetics.com or (. Company, its business: //www.businesswire.com/news/home/20220223006209/en/, Chromosomal sequencing Analysis ( CSA ).. Required information, providers can: Fulgent will fax the provider a summary the! At $ 30.83 on Monday it to Fulgent Genetics via email or fax cash at., medical actionability, and public holidays technology to Fulgents comprehensive suite of testing! # x27 ; s stock price to reach $ 41.67 in the so! Risk for hereditary cancer syndromes and established clinical management please completely fill out the institutional billing of... Relations section of the virus invades and replicates itself Genetics in 2011 and the company & # x27 s!